Israeli Pharma Co. To Pay $2M To End Stock-Drop Suit
Shareholders in Israeli pharmaceutical company Kitov Pharmaceuticals asked a New York federal judge on Friday to approve a $2 million deal to settle allegations the company and its CEO falsified late-stage...To view the full article, register now.
Already a subscriber? Click here to view full article